Clinical Trial Update: A Study of BMS-986340 as Monotherapy and in Combination With Nivolumab or Docetaxel in Participants With Advanced Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

This is a Phase 1/2 clinical trial evaluating BMS-986340 as monotherapy and in combination with nivolumab or docetaxel across several advanced solid tumors, cur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Colorectal Cancer
• Gastric Cancer
• Head and Neck Squamous Cell Carcinoma
• Non-small Cell Lung Cancer
• Pancreatic Adenocarcinoma
• Renal Cell Carcinoma
• Urothelial Carcinoma

Drugs mentioned

• BMS-986340
• DOCETAXEL (DOCETAXEL)
• nivolumab (nivolumab)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Cervical Cancer, Gastric/Gastroesophageal Junction Adenocarcinoma | Phase 1, Phase 2 | Status: RECRUITING